β-estradiol increases dentate gyrus inhibition in female rats via augmentation of hilar neuropeptide Y

Journal of Neuroscience

Volumn 27, Issue 22, 2007, Pages 6054-6063

  Velíšková, Jana ^a   Velíšek, Libor ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Dentate gyrus; Epilepsy; Estradiol; Neuronal excitability; Neuropeptide Y; Neuroprotection

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; ESTRADIOL; KAINIC ACID; METABOTROPIC RECEPTOR ANTAGONIST; NEUROPEPTIDE Y;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GRANULE CELL; IN VITRO STUDY; NERVE CELL LESION; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; UPREGULATION;

ANIMALS; DENTATE GYRUS; ESTRADIOL; FEMALE; NEURAL INHIBITION; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 34249818753     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0366-07.2007     Document Type: Article

References (71)

1. Baraban SC, Tallent MK (2004) Interneuron diversity series: interneuronal neuropeptides - endogenous regulators of neuronal excitability. Trends Neurosci 27:135-142.
2. Behr J, Lyson KJ, Mody I (1998) Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol 79:1726-1732.
3. Ben-Ari Y, Tremblay E, Riche D, Ghilini G, NaquetR (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6:1361-1391.
4. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG (2005) Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response elementbinding protein. J Neurosci 25:5066-5078.
5. Buckmaster PS, Schwartzkroin PA (1995) Interneurons and inhibition in the dentate gyrus of the rat in vivo. J Neurosci 15:774-789.
6. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD (1989) Hippocampus interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495:387-395.
7. Derbenev AV, Monroe MJ, Glatzer NR, Smith BN (2006) Vanilloidmediated heterosynaptic facilitation of inhibitory synaptic input to neurons of the rat dorsal motor nucleus of the vagus. J Neurosci 26:9666-9672.
8. Dube C, Brunson KL, Eghbal-Ahmadi M, Gonzalez-Vega R, Baram TZ (2005) Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. J Mol Neurosci 25:275-284.
9. 5 receptor subtype in the rat brain. J Neurosci 18:5565-5574.
10. El Bahh B, Lurton D, Sundstrom LE, Rougier A (1997) Induction of tolerance and mossy fibre neuropeptide-Y expression in the contralateral hippocampus following a unilateral intrahippocampal kainic acid injection in the rat. Neurosci Lett 227:135-139.
11. El Bahh B, Auvergne R, Lere C, Brana C, Le Gal La Salle G, Rougier A (2001) Decreased epileptic susceptibility correlates with neuropeptide Y overexpression in a model of tolerance to excitotoxicity. Brain Res 894:209-217.
12. El Bahh B, Cao JQ, Beck-Sickinger AG, Colmers WF (2002) Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br J Pharmacol 136:502-509.
13. El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, Gehlert DR, Vezzani A, Colmers WF (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22:1417-1430.
14. El-Bakri NK, Islam A, Zhu S, Elhassan A, Mohammed A, Winblad B, Adem A (2004) Effects of estrogen and progesterone treatment on rat hippocampal NMDA receptors: relationship to Morris water maze performance. J Cell Mol Med 8:537-544.
15. Engel Jr J (1989) Seizures and epilepsy. Philadelphia: Davis.
16. Engel Jr J, Williamson PD, Wieser H-G (1997) Mesial temporal lobe epilepsy. In: Epilepsy: a comprehensive textbook (Engel Jr J, Pedley TA, eds), pp 2417-2426. Philadelphia: Lippincot-Raven.
17. Fitzjohn SM, Bortolotto ZA, Palmer MJ, Doherty AJ, Ornstein PL, Schoepp DD, Kingston AE, Lodge D, Collingridge GL (1998) The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology 37:1445-1458.
18. Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470.
19. Fu LY, Acuna-Goycolea C, van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24:8741-8751.
20. Gobbi M, Gariboldi M, Piwko C, Hoyer D, Sperk G, Vezzani A (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 70:1615-1622.
21. Gruber CJ, Tschugguel W, Schneeberger C, Hyber JC (2002) Production and actions of estrogens. N Engl J Med 346:340-352.
22. B receptors. J Neurosci 16:4250-4260.
23. Hattiangady B, Rao MS, Shetty GA, Shetty AK (2005) Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp Neurol 195:353-371.
24. Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
25. Heinemann U, Beck H, Dreier JP, Ficker E, Stabel J, Zhang CL (1992) The dentate gyrus as a regulated gate for the propagation of epileptiform activity. Epilepsy Res Suppl 7:273-280.
26. Hoffman GE, Moore N, Fiskum G, Murphy AZ (2003) Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 182:124-134.
27. Hokfelt T (1991) Neuropeptides in perspective: the last ten years. Neuron 7:867-879.
28. Imwalle DB, Gustafsson JA, Rissman EF (2005) Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav 84:157-163.
29. Kalita K, Szymczak S, Kaczmarek L (2005) Non-nuclear estrogen receptor beta and alpha in the hippocampus of male and female rats. Hippocampus 15:404-412.
30. Kirkby DL, Higgins GA (1998) Characterization of perforant path lesions in rodent models of memory and attention. Eur J Neurosci 10:823-838.
31. Klapstein GJ, Colmers WF (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78:1651-1661.
32. Lothman EW, Stringer JL, Bertram EH (1992) The dentate gyrus as a control point for seizures in the hippocampus and beyond. Epilepsy Res Suppl 7:301-313.
33. Martin JL, Sloviter RS (2001) Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P. J Comp Neurol 436:127-152.
34. Mathern GW, Babb TL, Armstrong DL (1997) Hippocampal sclerosis. In: Epilepsy: a comprehensive textbook (Engel JJ, Pedley TA, eds), pp 133-155. Philadelphia: Lippincott-Raven.
35. McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384.
36. Medvedev A, Mackenzie L, Hiscock JJ, Willoughby JO (2000) Kainic acid induces distinct types of epileptiform discharge with differential involvement of hippocampus and neocortex. Brain Res Bull 52:89-98.
37. Milner TA, McEwen BS, Hayashi S, Li CJ, Reagan LP, Alves SE (2001) Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol 429:355-371.
38. Nakamura NH, McEwen BS (2005) Changes in interneuronal phenotypes regulated by estradiol in the adult rat hippocampus: a potential role for neuropeptide Y. Neuroscience 136:357-369.
39. Neal-Perry GS, Zeevalk GD, Santoro NF, Etgen AM (2005) Attenuation of preoptic area glutamate release correlates with reduced luteinizing hormone secretion in middle-aged female rats. Endocrinology 146:4331-4339.
40. Osterlund MK, Witt MR, Gustafsson JA (2005) Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics. Endocrine 28:235-242.
41. Pastalkova E, Serrano P, Pinkhasova D, Wallace E, Fenton AA, Sacktor TC (2006) Storage of spatial information by the maintenance mechanism of LTP. Science 313:1141-1144.
42. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4: Academic.
43. Pitkanen A, Nissinen J, Nairismagi J, Lukasiuk K, Grohn OH, Miettinen R, Kauppinen R (2002) Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 135:67-83.
44. Ratzliff AH, Howard AL, Santhakumar V, Osapay I, Soltesz I (2004) Rapid deletion of mossy cells does not result in a hyperexcitable dentate gyrus: implications for epileptogenesis. J Neurosci 24:2259-2269.
45. Ravizza T, Galanopoulou AS, Velíšková J, Moshé SL (2002) Sex differences in androgen and estrogen receptor expression in rat substantia nigra during development: an immunohistochemical study. Neuroscience 115:685-696.
46. Redrobe JP, Dumont Y, Herzog H, Quirion R (2004) Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci 22:159-166.
47. Reibel S, Andre V, Chassagnon S, Andre G, Marescaux C, Nehlig A, Depaulis A (2000) Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci Lett 281:79-82.
48. Reibel S, Benmaamar R, Le BT, Larmet Y, Kalra SP, Marescaux C, Depaulis A (2003) Neuropeptide Y delays hippocampal kindling in the rat. Hippocampus 13:557-560.
49. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24:3051-3059.
50. Rudick CN, Woolley CS (2001) Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21:6532-6543.
51. Schwarzer C, Sperk G (1998) Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors. Hippocampus 8:274-288.
52. Silva AP, Carvalho AP, Carvalho CM, Malva JO (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J Neurochem 79:286-296.
53. Silva AP, Xapelli S, Grouzmann E, Cavadas C (2005) The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr Drug Targets CNS Neurol Disord 4:331-347.
54. Smialowska M, BajkowskaM (1997) Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies. Pol J Pharmacol 49:357-362.
55. Smith CC, McMahon LL (2005) Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J Neurosci 25:7780-7791.
56. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M (1992) Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 50:831-846.
57. Tashiro A, Sandler VM, Toni N, Zhao C, Gage FH (2006) NMDA-receptormediated, cell-specific integration of new neurons in adult dentate gyrus. Nature 442:929-933.
58. Titolo D, Cai F, Belsham DD (2006) Coordinate regulation of Neuropeptide Y and Agouti-related peptide gene expression by estrogen depends on the ratio of ERα to ERβ in clonal hypothalamic neurons. Mol Endocrinol 20:2080-2092.
59. Tu B, Timofeeva O, Jiao Y, Nadler JV (2005) Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 25:1718-1729.
60. Velíšek L, Velíšková J (2002) Estrogen treatment protects GABA(B) inhibition in the dentate gyrus of female rats after kainic acid-induced status epilepticus. Epilepsia 43 [Suppl 5]:146-151.
61. Velíšek L, Veĺšková J, Etgen AM, Stanton PK, Moshé SL (1999) Regionspecific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res 842:132-138.
62. Velíšková J (2003) The role of neuropeptide Y in estrogen-induced neuroprotective effects on status epilepticus-associated hippocampal cell loss. Epilepsia 44 [Suppl 9]:206.
63. Velíšková J (2006) The role of estrogens in seizures and epilepsy: the bad guys or the good guys? Neuroscience 138:837-844.
64. Velíšková J (2007) Estrogens and epilepsy: why are we so excited? Neuroscientist 13:77-88.
65. Velíšková J, Velíšek L, Galanopoulou AS, Sperber EF (2000) Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41:S30-S35.
66. Vezzani A, Sperk G (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides 38:245-252.
67. Vezzani A, Sperk G, Colmers WF (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:25-30.
68. West MJ (2002) Design-based stereological methods for counting neurons. Prog Brain Res 135:43-51.
69. Wielgosz-Collin G, Duflos M, Pinson P, Le Baut G, Renard P, Bennejean C, Boutin J, Boulanger M (2002) 8-Amino-5-nitro-6-phenoxyquinolines: potential non-peptidic neuropeptide Y receptor ligands. J Enzyme Inhib Med Chem 17:449-453.
70. Woldbye DP, Nanobashvili A, Sorensen AT, Husum H, Bolwig TG, Sorensen G, Ernfors P, Kokaia M (2005) Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol Dis 20:760-772.
71. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848-1859.